Here’s What We Are Looking For From The Upcoming Dimension Therapeutics Inc (DMTX) Data

Dimension Therapeutics Inc (NASDAQ:DMTX) reported at the end of last week that it will present data from its phase 1/2 clinical trial of DTX101 for the treatment of hemophilia...

Keep Reading →